Two synthetic peptides — Shuffle and Penetramax — effectively improved intestinal drug absorption at 50 µM while causing minimal disruption to gut bacteria.
2 out of 9 CPPsShuffle and Penetramax were the only cell-penetrating peptides that effectively improved intestinal permeability while minimizing harm to gut bacteria.
What the researchers found
Out of 9 cell-penetrating peptides tested, 4 significantly improved intestinal paracellular permeability without compromising cell health. Among these, the synthetic CPPs Shuffle and Penetramax were the top performers, increasing permeability at 50 µM concentration while having only small to moderate antimicrobial effects on tested gut commensal strains. The other 4 CPPs that improved permeability had more substantial negative effects on nearly all tested gut bacteria.
Why it matters
Many promising drugs fail because they can't be absorbed orally, forcing patients to use injections instead. Finding peptides that safely improve gut absorption — without destroying beneficial gut bacteria — could make oral delivery feasible for a much wider range of therapeutics, improving patient compliance and quality of life.
How the study worked
Researchers tested 9 CPPs using a differentiated Caco-2 epithelial monolayer model (a standard lab model of the intestinal barrier). Cytotoxicity was measured with Cytotox Red dye staining, cell viability with AlamarBlue staining, and paracellular permeability by transport assays. The 4 best-performing CPPs were then tested against 10 representative gut bacteria strains using microbroth dilution assays.
What this study cannot tell us
All experiments were conducted in vitro using cell monolayers and isolated bacterial strains, which may not fully reflect the complex environment of the human gut. The study did not test actual drug absorption with these CPPs, only permeability markers. In vivo studies are needed to confirm safety and efficacy in living organisms.
How to read the evidence
This is an in vitro screening study using established cell models and bacterial assays. It provides solid preliminary evidence for candidate selection, but lacks in vivo validation needed for stronger evidence grading.
When this study was published
Published in 2022, this study is recent and addresses an active area of pharmaceutical research on oral drug delivery using peptides.
The bigger picture
The growing interest in oral peptide and biologic delivery has made cell-penetrating peptides a hot area of research. This study adds an important dimension by evaluating microbiome safety alongside absorption efficiency — a factor that is increasingly recognized as critical for any oral drug delivery strategy.
Questions still open
- Do Shuffle and Penetramax maintain their permeability-enhancing effects in vivo?
- What is the long-term impact of repeated CPP exposure on gut microbiome diversity?
- Can these CPPs effectively improve absorption of specific therapeutic peptides or biologics?
Common questions
What are cell-penetrating peptides and why do they matter for drug delivery?
Could these peptides harm the gut microbiome?
Read the original research
Screening for effective cell-penetrating peptides with minimal impact on epithelial cells and gut commensals in vitro.
Frontiers in pharmacology, 13, 1049324
Citation
Gelli, Hitesh P; Vazquez-Uribe, Ruben; Sommer, Morten Otto Alexander. (2022). Screening for effective cell-penetrating peptides with minimal impact on epithelial cells and gut commensals in vitro.. Frontiers in pharmacology, 13, 1049324. https://doi.org/10.3389/fphar.2022.1049324